Appen Ltd (ASX: APX) and these ASX shares could be among the best options for investors in 2021. Here’s what you need to know…
The post 4 of the best ASX shares to buy in 2021 appeared first on The Motley Fool Australia. –
If you’re looking to make some investments in 2021, then you might want to take a look at the ASX shares listed below.
Here’s why these four ASX shares have been named as buys for next year:
Altium Limited (ASX: ALU)
The first share to look at is Altium. It is an award-winning printed circuit board design software provider which has carved out a leading position in this growing market over the last few years. It is now aiming to take things to the next level and dominate the market with its cloud-based Altium 365 platform. One broker that likes what it sees here is Credit Suisse. Last week it initiated coverage on Altium with an outperform rating and $42.00 price target.
Appen Ltd (ASX: APX)
Another option to look at is Appen. It is a leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI). Appen’s team of over one million contractors prepare and/or create the data for the machine learning models of some of the largest tech companies. This includes tech behemoths Facebook and Microsoft. Analysts at Macquarie are positive on Appen and have an outperform rating and $43.00 price target on its shares. The broker appears confident on the company’s long term growth potential thanks to the AI tailwind.
IDP Education Ltd (ASX: IEL)
A third share to look at is IDP Education. It is a provider of international student placement and English language testing services. While it has been hit hard by the pandemic, it has been tipped to come out of the crisis in an even stronger position. This could make it a big winner when COVID-19 vaccines are rolled out and international travel resumes. Analysts at Morgans like the company and have an add rating and $25.09 price target on its shares. The broker believes the company is well-placed for growth once trading conditions return to normal.
ResMed Inc. (ASX: RMD)
A final option is ResMed. It is a medical device company with a focus on the sleep treatment market. ResMed has been growing at a strong rate over the last decade thanks to its industry-leading products in a growing market. Pleasingly, the company still has a significant runway for growth in the future. Management estimates that there are ~1 billion people suffering from sleep apnoea worldwide and only ~20% of these sufferers have been diagnosed. Morgans is also positive on ResMed and has an add rating and $30.99 price target on its shares.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
- Here’s how the S&P/ASX All Technology Index fared in 2020
- Buy these ASX blue chip shares in 2021
- The ASX tech shares to buy in 2021
- ASX 200 down 0.8%: Big four banks and tech shares drag the market lower
- 2 explosive ASX growth shares to buy for 2021
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Altium. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Appen Ltd and Idp Education Pty Ltd. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.